REVIVA PHARMACEUTCLS HLDGS I RVPHW
*W EXP 12/25/202 · Equity WRT · CUSIP 76152G118
4
institutional holders
-1 vs Q1 2023
144.4k
shares reported held*
$254.0kreported value*
0 new
0 added
2 reduced
1 sold out
net sold ≈ $66.4k (-37.5k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.76.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 7 |
| Q4 2022 | 5 |
| Q1 2023 | 5 |
| Q2 2023 | 4 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 5 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 0 | 3 |
Biggest buyers
| None |
Biggest sellers
| Walleye Capital LLC | Reduced | -20.6k |
| Walleye Trading LLC | Reduced | -15.2k |
| UBS Group AG | Sold out | -1.7k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Arena Investors LP 0.14% of their portfolio | 85.0k $148.8k | Unchanged |
| Walleye Capital LLC 0.00% of their portfolio | 33.7k $59.7k | Reduced -20.6k |
| Walleye Trading LLC 0.00% of their portfolio | 25.7k $45.6k | Reduced -15.2k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |